TrialInternal medicine (Tokyo, Japan)

Dual Impact of Tolvaptan on Intracellular and Extracellular Water in Chronic Kidney Disease Patients with Fluid Retention.

Takahiro Masuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.